Human being has evolved with an unending quest for exploration. With constant
research in medical and other sciences, molecular diagnostic tools and
techniques were developed. Besides providing the medical work and a wider
spectrum and accuracy of test findings, these tests have also enabled
researchers to establish new findings about human body which is proving a boon
against the rising complexities of health care in the present world. The
global market of molecular diagnostics has increased significantly in the
recent past and is anticipated to expand invariably in the years to come. The
market is projected to record a CAGR of approximately 13.1% for the period
spanning 2012-2014.
Testing for established infectious diseases such as HPV, CT/GC, and hepatitis,
among others, represents the largest market category in terms of revenue
generation. However, with the realm of molecular diagnostic testing in cancer
screening undergoing a major change, the Oncology segment of the market will
witness significant expansion in the times to come, driving the overall market
for molecular diagnostics. Geographically, the US is the largest regional
market in worldwide molecular diagnostics industry, with Europe and Japan
trailing behind the US. While, these regions will continue to dominate the
molecular diagnostics landscape, the emerging regions are expected to
experience the fastest growth.
The global molecular diagnostics market is presently characterized by growth
in large value mergers and acquisitions and shifting focus towards tailored
therapy and personalized treatment, especially in the field of Oncology.
Further, rising incidences of genetic diseases unfolds new opportunities for
genetic testing in the molecular diagnostics market. Further, the ever
escalating demand for better healthcare solutions, coupled with ageing world
population and rising new incidences of cancer are governing the global
molecular diagnostics market growth, taking it to new heights. However, the
global molecular diagnostics marketplace continues to be plagued by challenges
in the form of rising price pressures and growing regulatory hurdles.
The intensely competitive and fragmented global molecular diagnostics market
is mainly led by a few large players. Roche, Qiagen, Gen-Probe, Novartis,
Cepheid, and Becton Dickinson, are among the top notch players in the industry.
The current report analyzes the global molecular diagnostic market. It also
presents a view of the various segments of the market. The report discusses
the drivers and challenges prevailing in the molecular diagnostics industry.
It presents the competitive conditions prevailing in the global molecular
diagnostic market, along with the profiles of major players.
By combining SPSS Inc.'s data integration and analysis capabilities with our
relevant findings, we have predicted the future growth of the industry. We
employed various significant variables that have an impact on this industry
and created regression models with SPSS Base to determine the future direction
of the industry. Before deploying the regression model, the relationship
between several independent or predictor variables and the dependent variable
was analyzed using standard SPSS output, including charts, tables and tests.
Table of Contents
Table of Contents
1. Overview
1.1. In Vitro Diagnostics: Industry Overview
1.2. Molecular diagnostics
2. Global Market Structure
2.1. Global IVD Market
2.1.1. Global Market Size
2.1.2. Market Segmentation
2.1.3. Competitive Scenario in IVD Market
2.2. Global Molecular Diagnostics Market
2.2.1. Global Market Size
2.2.2. Market by Segments
2.2.3. Market by Regions
2.3. Molecular Diagnostics Segments Analysis
2.3.1. HPV
2.3.2. CT/GC
2.3.3. Influenza
3. Molecular Diagnostics - Market Dynamics
3.1. Trends & Developments
3.1.1. Molecular Diagnostics in Oncology: Focus on Personalized Treatment
3.1.2. Growing M&A Activity in the Molecular Diagnostics Landscape
3.1.3. Emerging Korean Molecular Diagnostics Business
3.1.4. Growth in Genetic Testing
3.1.5. Development of Industry's First Real-Time “Multiplex
Quantification” Molecular Diagnostic Testing Technology
3.3. Growth Drivers
3.3.1. Growing Ageing Population
3.3.2. Rising Demand for Better Healthcare Options
3.3.3. Rise in Healthcare Spending
3.4. Challenges
3.4.1. Increasing Safety Regulations
3.4.2. Escalating Price Pressure
4. Molecular Diagnostics - Competitive Scenario
Competitive Overview
Market Share
Peer Comparison
5. Company Profiles
5.1. Roche Holdings AG
Business Description
Key Financials
Business Strategies
Focus On Innovative Diagnostics
Leverage Expertise in Molecular Biology
5.2. Novartis AG
Business Description
Key Financials
Business Strategies
Sustained Investment in Innovation
Expansion in High-Growth Markets
5.3. Qiagen N.V.
Business Description
Key Financials
Business Strategies
Complete Automation Systems
Continuously Adding New Test Content
5.4. Gen-Probe Incorporated
Business Description
Key Financials
Business Strategies
Expanding Product Portfolio
Market Expansion within Clinical Diagnostics
6. Market Outlook
6.1. Market Forecast
6.2. Forecast Methodology
6.2.1. Dependent and Independent Variables
6.2.2. Correlation Analysis
6.2.3. Regression Analysis
List of Charts
IVD Market - Segments by Technology
Molecular Diagnostcs - Traditional Process
Main Purposes of Molecular Diagnostics
Global In-Vitro Diagnostics Market Revenues, 2004-2010
Growth in Global In-Vitro Diagnostics Market, 2005-2016F
Global IVD Market Classification by Segments, 2011
Global IVD Market by Regions, 2010 & 2015F
Market Share of Leading Players in the Global IVD Market, 2010
Global Molecular Diagnostics Market, 2007-2011
Global Molecular Diagnostics Market Breakup by Segments, 2010 & 2015F
Global Molecular Diagnostics Market Breakup by Application Areas, 2010
Global Molecular Diagnostics Market Breakdown by Regions, 2010
Number of Molecular Diagnostic Products Approved in the US, 2010
Global Molecular HPV Testing Market, 2010-2013E
HPV Testing Market Penetration Rates in the US, 2010-2013E
Global CT/GC Market Revenues, 2011
Global CT/GC Market Share by Leading Companies, 2011
The US Market for Influenza Diagnostic Tests, 2010
Current Standards of Care in Various Therapeutic Areas, 2011
Mergers & Acquisitions in Molecular Diagnostics Sector, 2008-2010
Number of Genetic Tests and Laboratories Available Worldwide, 1993-2011
Global Ageing Population, 2005-2013F
Global Healthcare Spending, 2005-2010
Global Molecular Diagnostic Market Share by Companies, 2011
Leading Players in PCR Based Global Molecular Diagnostics Market, 2010
Roche's Revenues by Business Segments, 2011
Roche's Revenues and Net Income, 2007-2011
Novartis' Revenues by Business Segments, 2011
Novartis' Revenues and Net Income, 2007-2011
Qiagen's Revenues Share by Source of Revenues, 2011
Qiagen's Revenues and Net Income, 2007-2011
Gen-Probe's Revenues Share by Source of Revenues, 2011
Qiagen's Revenues and Net Income, 2007-2011
Global Molecular Diagnostics Market Forecast, 2010-2014F
List of Tables
Patients Worldwide Waiting for Better Treatment Options, 2011
Non-PCR Amplification Processes
Global Peer Comparison in the Molecular Diagnostics Market, 2011
Global Molecular Diagnostic Companies - Proprietary Technology
Dependent & Independent Variables, 2004-2010
Correlation Matrix
Model Summary - Coefficient of Determination
Regression Coefficients Output
Global Molecular Diagnostics Market Report: 2012 Edition published by Koncept Analytics in July 25, 2012. This report consists of 46 Pages and the price starts from US $ 800.
The contents of this page may be different from the latest version. Please contact us for details.
